1Nair P. Early interventions with inhaled corticosteroids in asthma: benefits and risks[ J]. Curr Opin Pulm Med ,2011,17 ( 1 ) : 12 - 15.
2Davis SQ, Krishnan JA, Lee K, et al. Effect of a community -wide asthma intervention on appropriate use of inhaled corticosteroids[ J]. J Urban Health,2011,88 ( Suppl 1 ) : 144 - 155.
3Grzanka A, Jarzab J. Difficulties in determining of the equivalent doses of inhaled glucocorticoids[ J ]. Pol Merkur Lekarski, 2010, 28(164) :134 - 137.
4Cerasoli F Jr. Developing the ideal inhaled corticosteroid [ J ]. Chest,2006,130( 1 Suppl) :54S -64S.
5Allen DR, Bielory L, Derendorf H, et al. Inhaled corticosteroids past lessons and future issues [ J ]. J Allergy Clin Immunol 2003,112(3) :1 -40.
6Leach CL, Bet hke TD, Boudreau R J, et al. Two - dimensional and threedimensional imaging show ciclesonide has high lung depo- sition and peripheral distribution: a nonrandomized study in healthy volunteers [ J ]. J Aerosol Med, 2006,19 ( 2 ) : 117 - 126.
7Newman S, Salmon A, 1Nave it, et al. High lung deposition ol 99mTc -labeled ciclesonide administered via HFA - MDI to patients with asthma [ J ]. Respir Med, 2006 , 100 ( 3 ) : 375 - 384.
8Rohatagi S, Luo Y, Shen L,et al. Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide [ J ]. Am J Ther, 2005,12 ( 3 ) :201 - 209.
9Leach CL, Davidson PJ, Hasselquist BE. Lung deposition of hydrofluoroalkane- 134a beelomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone. a cross -over study in healthy volunteers [J]. Chest, 2002,122(2) :510 -516.
10Stephen B, Shrewsbury, Andrew P, et al. Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma[J], lnt J Pharm, 2009,365( 1 -2) :12 -17.
9Nair P.Early interventions with inhaled corticosteroids in asthma:benefits and risks[J].Curr Opin Pulm Med,2011,17(1):12-15.
10Atkins D,Briss PA,Eccles M,et al.Systems for grading the quality of evidence and the strength of recommendation Ⅱ:pilot study of a new system[J].BMC Health ServRes,2005,5(1):25.